Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen in Duchenne muscular dystrophy (ambulant children)
2017-004554-42Phase 3Terminated
- Sponsor
- University Children's Hospital Basel
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Tamoxifen arm with Placebo arm (2 arms). Primary endpoint: Change in MFM D1 subscore (standing and transfers). Started Jul 2018; status: terminated.
02
Drugs
tamoxifen
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2017-004554-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004554-42.